EconPapers    
Economics at your fingertips  
 

Common ownership in the US pharmaceutical industry: A network analysis

Albert Banal-Estanol, Melissa Newham and Jo Seldeslachts

No 663270, Working Papers of Department of Management, Strategy and Innovation, Leuven from KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven

Abstract: We investigate patterns in common ownership networks between firms that are active in the US pharmaceutical industry for the period 2004-2014. Our main findings are that “brand firms” —i.e. firms that have R&D capabilities and launch new drugs—exhibit relatively dense common ownership networks with each other that further increase significantly in density over time, whereas the network of “generic firms” —i.e. firms that primarily specialize in developing and launching generic drugs— is much sparser and stays that way over the span of our sample. Finally, when considering the common ownership links between brands firms, on the one hand, and generic firms, on the other, we find that brand firms have become more connected to generic firms over time. We discuss the potential antitrust implications of these findings.

Keywords: Common ownership networks; pharmaceutical companies; competition; innovation (search for similar items in EconPapers)
Pages: 49
Date: 2020-11-16
New Economics Papers: this item is included in nep-ino and nep-net
Note: paper number MSI_2012
References: Add references at CitEc
Citations:

Published in MSI Working Paper, volume MSI_2012, issue MSI_2012, pages 1-49

Downloads: (external link)
https://lirias.kuleuven.be/retrieve/594092 Published version (application/pdf)

Related works:
Journal Article: Common Ownership in the U.S. Pharmaceutical Industry: A Network Analysis (2021) Downloads
Working Paper: Common Ownership in the US Pharmaceutical Industry: A Network Analysis (2020) Downloads
Working Paper: Common Ownership in the US Pharmaceutical Industry: A Network Analysis (2020) Downloads
Working Paper: Common ownership in the US pharmaceutical industry: A network analysis (2020) Downloads
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ete:msiper:663270

Access Statistics for this paper

More papers in Working Papers of Department of Management, Strategy and Innovation, Leuven from KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven
Bibliographic data for series maintained by library EBIB ().

 
Page updated 2025-03-30
Handle: RePEc:ete:msiper:663270